3rd Quarter - Report

INVACARE CORPORATION for INVACARE CORPORATION

Period 3rd Quarter 2008 Filed Oct 10, 2008 Signed by Cara C. Bachenheimer, Senior Vice President, Government Relations

Official filing
Firm
INVACARE CORPORATION
Client
INVACARE CORPORATION
Income
—
Expenses
$276,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Changes to Medicare regarding durable medical equipment benefits. H.R. 2231 - Medicare Access to Complex Rehabilitation and Assistive Technology Act of 2007; H.R. 1845/S. 1428 - Medicare Durable Medical Equipment Access Act of 2007 and H.R. 621 and S. 1484 - The Home Oxygen Patient Protection Act

LobbyistCovered position, as disclosed
CARA C BACHENHEIMER N/A
MICHAEL BROMBERG N/A
SHAWN COUGHLIN N/A
FREDERICK H GRAEFE N/A
JENNIFER HIGGINS N/A
STEVEN JENNING N/A

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: S. 1428 (110th), H.R. 621 (110th), S. 1484 (110th), H.R. 1845 (110th), H.R. 2231 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.